Public IDs No public external ID is attached.
Related people No reviewed person affiliation is attached.
Outputs No reviewed output is linked through affiliated people.
Relationship evidence PRODUCED BY incoming 82% confidence
PRODUCED BY incoming 82% confidence
Timeline No dated relationship evidence is attached.
Evidence status source linked
Cross-source check Single reviewed source
Source ClinicalTrials.gov Testing the Addition of the Drug Relugolix to the Usual Radiation Therapy for Advanced-Stage Prostate Cancer, The NRG Promethean Study
Publisher ClinicalTrials.gov
Date Jun 25, 2026
Trust tier clinical-trials
License ClinicalTrials.gov public registry record Source ClinicalTrials.gov Testing the Addition of a New Anti-Cancer Drug, Niraparib, to the Usual Treatment (Hormone and Radiation Therapy) for Prostate Cancer With a High Chance of Recurring
Publisher ClinicalTrials.gov
Date Jul 10, 2026
Trust tier clinical-trials
License ClinicalTrials.gov public registry record